This could be partly explained by the limited protection of Nrf2 against disease markers in backcross experiments between ALS mice and Nrf2-null mice, presumably as a result of compensatory mechanisms (Vargas et al. 2013; Guo et al. 2013b). Here, NFE2L2 is linked to amyotrophic lateral sclerosis.